MedPath

Comparison between the PENG block and the supra-inguinal fascia iliaca compartment block on postoperative pain, total opioids consumption and early motor recovery after total hip arthroplasty

Phase 1
Conditions
Total hip arthroplasty by postero-lateral approach
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2020-005126-28-BE
Lead Sponsor
CHU de Liège
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients >18 years old
Classified as ASA 1-2-3
Admitted for elective total hip arthroplasty surgery by poster-lateral approach under spinal anesthesia
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 50

Exclusion Criteria

Exclusion criteria included refusal of the patient and contraindications to the performance of SFICB or PENG block such as known allergy to used medications or local infection.
Other exclusion criteria included pregnancy, obesity with body mass index > 35, emergency hip arthroplasty or previous surgery on the same joint,
history of drug addiction, treatment with corticosteroids for more than 6 months, uncontrolled systemic arterial hypertension, severe kidney or liver diseases, and mental disorders or serious neurological diseases.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath